SYNCONA PARTNERS LLP
Syncona is a leading healthcare company focused on investing in and building global leaders in life science. Their vision is to deliver transformational treatments to patients in truly innovative areas of healthcare while generating superior returns for shareholders. They seek to partner with the best, brightest and most ambitious minds in science to build globally competitive businesses. They take a long-term view, underpinned by a deep pool of capital, and are established leaders in the devel... opment of genetic medicine, particularly gene and cell therapy. They focus on delivering dramatic efficacy for patients in areas of high unmet need. Syncona is aligned with two of the premium charitable funders in UK science, The Wellcome Trust, original founder of Syncona, and Cancer Research UK, both of which are significant shareholders in their business. They make a donation of 0.3% of Net Asset Value to a range of charities each year.
SYNCONA PARTNERS LLP
Social Links:
Industry:
Biotechnology Financial Services Health Care Venture Capital
Founded:
2012-01-01
Status:
Active
Contact:
0871 664 0321
Email Addresses:
[email protected]
Technology used in webpage:
GlobalSign Domain Verification Microsoft Azure UK South Region
Current Employees Featured
Founder
Stock Details
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-05-18 | SwanBio Therapeutics | Syncona Partners LLP investment in Series B - SwanBio Therapeutics | 56 M USD |
| 2022-04-27 | OMass Technologies | Syncona Partners LLP investment in Series B - OMass Technologies | 75.5 M GBP |
| 2022-03-10 | Freeline | Syncona Partners LLP investment in Post-IPO Equity - Freeline | 26.1 M USD |
| 2021-12-16 | Anaveon | Syncona Partners LLP investment in Series B - Anaveon | 110 M CHF |
| 2021-11-29 | Quell Therapeutics | Syncona Partners LLP investment in Series B - Quell Therapeutics | 156 M USD |
| 2021-11-03 | Clade Therapeutics | Syncona Partners LLP investment in Series A - Clade Therapeutics | 87 M USD |
| 2021-03-26 | Gyroscope Therapeutics | Syncona Partners LLP investment in Series C - Gyroscope Therapeutics | 107.8 M GBP |
| 2021-02-11 | Quell Therapeutics | Syncona Partners LLP investment in Series A - Quell Therapeutics | 40 M USD |
| 2020-12-02 | Resolution Therapeutics | Syncona Partners LLP investment in Series A - Resolution Therapeutics | 26.6 M GBP |
| 2020-11-19 | Purespring Therapeutics | Syncona Partners LLP investment in Series A - Purespring Therapeutics | 45 M GBP |